^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    SSAT activator

    Related drugs:
    1year
    PACES: S0820, Adenoma and Second Primary Prevention Trial (clinicaltrials.gov)
    P3, N=354, Active, not recruiting, SWOG Cancer Research Network | Recruiting --> Active, not recruiting | N=1340 --> 354
    Enrollment closed • Enrollment change
    |
    Flynpovi (eflornithine/sulindac)